Owlstone, Thermo Fisher team up for early disease detection
If successful, Thermo’s mass analyser will become a standard part of Owlstone Medical’s biomarker discovery process.
Read More
Tag: breath biopsy
GSK to use Owlstone’s breath biopsy in COPD trial
In a major boon for UK diagnostics group Owlstone Medical, GlaxoSmithKline is incorporating the firm’s Breath Biopsy platform into the clinical development programme for its novel, experimental respiratory drug danirixin.
Read More
Owlstone Medical, CR UK test potential of breath test for cancer
UK diagnostics group Owlstone Medical and Cancer Research UK have kicked off a study aiming to identify breath biomarkers to improve the early detection and diagnosis of multiple cancer types.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
